+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Norditropin"

From
Human Growth Hormone Market Report 2025 - Product Thumbnail Image

Human Growth Hormone Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Norditropin is a brand of human growth hormone (HGH) used to treat endocrine and metabolic disorders. It is a recombinant DNA-derived HGH, which is identical to the naturally occurring hormone produced in the body. Norditropin is used to treat growth failure in children and adults due to inadequate secretion of endogenous growth hormone, as well as to treat short stature associated with Turner syndrome, Prader-Willi syndrome, and chronic renal insufficiency. It is also used to treat adults with growth hormone deficiency. Norditropin is available in a variety of dosage forms, including injection pens, cartridges, and vials. It is administered subcutaneously, usually once daily. The most common side effects of Norditropin include injection site reactions, headache, and upper respiratory tract infection. The market for Norditropin is highly competitive, with several companies offering similar products. Some of the major players in the market include Novo Nordisk, Pfizer, Eli Lilly, Merck, and Sanofi. Show Less Read more